Abstract
Purpose
To evaluate the repeatability of the steady-state pattern electroretinogram (PERG) and full-field flicker electroretinogram (Flicker ERG) protocols, delivered by the office-based Neuro Optic Vision Assessment (NOVA)™ testing platform, in healthy subjects.
Methods
Healthy individuals underwent PERG (16° and 24°) and Flicker ERG [fixed luminance (FL) and multi-luminance (ML)] testing protocols. Test–retest repeatability of protocols was calculated using intra-class correlation coefficients (ICC). Reference values of the parameters of the aforementioned tests were also calculated.
Results
The ICCs for the PERG parameters ranged from 0.793 to 0.911 (p < 0.001). The ICCs for the Flicker ERG parameters ranged from 0.968 to 0.994 (p < 0.001). A linear regression analysis was applied to assess the impact of age on ERG responses. Age had a significant impact on all PERG parameters (16° or 24°). The phase response of the FL Flicker ERG significantly decreased with age (β = − 0.837, p ≤ 0.001). The FL Flicker ERG Magnitude was also impacted with a significant quadratic effect of age (β = − 0.0047, p = 0.0004). Similarly, the Phase Area Under the Curve (Phase AUC) of the ML Flicker ERG significantly declined with age (β = − 0.007, p = 0.009), and the impact on the Magnitude AUC was significant as well, with a negative quadratic age effect.
Conclusions
The PERG and Flicker ERG protocols, delivered by an office-based testing platform, were shown to have good-to-excellent test–retest repeatability when tests were performed in the same order and in immediate succession.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10633-019-09707-5/MediaObjects/10633_2019_9707_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10633-019-09707-5/MediaObjects/10633_2019_9707_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10633-019-09707-5/MediaObjects/10633_2019_9707_Fig3_HTML.png)
Similar content being viewed by others
References
Csaky K, Ferris F 3rd, Chew EY et al (2018) Report from the NEI/FDA endpoints workshop on age-related macular degeneration and inherited retinal diseases. Investig Ophthalmol Vis Sci 58:3456–3463. https://doi.org/10.1167/iovs.17-22339
Weinreb RN, Kaufman PL (2011) Glaucoma research community and FDA look to the future, II: NEI/FDA glaucoma clinical trial design and endpoints symposium: measures of structural change and visual function. Investig Ophthalmol Vis Sci 52:7842–7851
Nair P, Aiello LP, Gardner TW et al (2016) Report from the NEI/FDA diabetic retinopathy clinical trial design and endpoints workshop. Investig Ophthalmol Vis Sci 57:5127–5142. https://doi.org/10.1167/iovs.16-20356
Weinreb RN, Kaufman PL (2009) The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER glaucoma clinical trial design and endpoints symposium. Investig Ophthalmol Vis Sci 50:1497–1505. https://doi.org/10.1167/iovs.08-2843
Csaky KG, Richman EA, Ferris IIIFL (2008) Report from the NEI/FDA ophthalmic clinical trial design and endpoints symposium. Investig Ophthalmol Vis Sci 49:479–489. https://doi.org/10.1167/iovs.07-1132
Chew SS, Kerr NM, Wong AB et al (2016) Anxiety in visual field testing. Br J Ophthalmol 100:1128–1133. https://doi.org/10.1136/bjophthalmol-2015-307110
Bach M, Brigell MG, Hawlina M et al (2013) ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol 126:1–7. https://doi.org/10.1007/s10633-012-9353-y
McCulloch DL, Marmor MF, Brigell MG et al (2015) ISCEV standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130:1–12. https://doi.org/10.1007/s10633-014-9473-7
Wilsey LJ, Fortune B (2016) Electroretinography in glaucoma diagnosis. Curr Opin Ophthalmol 27:118–124. https://doi.org/10.1097/icu.0000000000000241
Porciatti V (2015) Electrophysiological assessment of retinal ganglion cell function. Exp Eye Res 141:164–170. https://doi.org/10.1016/j.exer.2015.05.008
Harwerth RS, Carter-Dawson L, Smith EL 3rd et al (2004) Neural losses correlated with visual losses in clinical perimetry. Invest Ophthalmol Vis Sci 45:3152–3160. https://doi.org/10.1167/iovs.04-0227
Hood DC, Kardon RH (2007) A framework for comparing structural and functional measures of glaucomatous damage. Prog Retin Eye Res 26:688–710. https://doi.org/10.1016/j.preteyeres.2007.08.001
Quigley HA, Dunkelberger GR, Green WR (1989) Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 107:453–464
Lasta M, Pemp B, Schmidl D et al (2013) Neurovascular dysfunction precedes neural dysfunction in the retina of patients with type 1 diabetes. Invest Ophthalmol Vis Sci 54:842–847. https://doi.org/10.1167/iovs.12-10873
Shunsuke Y, Shu K, Shinji U et al (2015) Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion. Acta Ophthalmol 93:e465–e468. https://doi.org/10.1111/aos.12674
Zele AJ, Feigl B, Kambhampati PK et al (2015) A method for estimating intrinsic noise in electroretinographic (ERG) signals. Doc Ophthalmol 131:85–94. https://doi.org/10.1007/s10633-015-9510-1
Derr PH, Gonzalez Garcia AO, Urgiles C et al (2014) Steady state pattern electroretinography (ssPERG) in age-related macular degeneration (AMD) compared to controls. Investig Ophthalmol Vis Sci 55:3973
Urgiles C, Tello C, Derr PH et al (2014) Evaluation of steady state pattern electroretinography (ssPERG) in discriminating normal from glaucoma suspect and glaucomatous eyes. Investig Ophthalmol Vis Sci 55:5609
Mavilio A, Scrimieri F, Errico D (2015) Can variability of pattern ERG signal help to detect retinal ganglion cells dysfunction in glaucomatous eyes? Biomed Res Int 2015:571314. https://doi.org/10.1155/2015/571314
Banitt MR, Ventura LM, Feuer WJ et al (2013) Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects. Investig Ophthalmol Vis Sci 54:2346–2352. https://doi.org/10.1167/iovs.12-11026
Cicchetti D (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instrument in psychology
Wolak ME, Fairbairn DJ, Paulsen YR (2012) Guidelines for estimating repeatability. Methods Ecol Evol 3:129–137. https://doi.org/10.1111/j.2041-210X.2011.00125.x
Fleiss JL (1999) Reliability of measurement. In: Fleiss JL (ed) The design and analysis of clinical experiments. Wiley, pp. 1–32
Bowd C, Tafreshi A, Vizzeri G et al (2009) Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection. J Glaucoma 18:437–442. https://doi.org/10.1097/IJG.0b013e31818c6f44
Asakawa K, Amino K, Iwase M et al (2017) New mydriasis-free electroretinogram recorded with skin electrodes in healthy subjects. Biomed Res Int 2017:8539747. https://doi.org/10.1155/2017/8539747
Fredette MJ, Anderson DR, Porciatti V, Feuer W (2008) Reproducibility of pattern electroretinogram in glaucoma patients with a range of severity of disease with the new glaucoma paradigm. Ophthalmology 115:957–963. https://doi.org/10.1016/j.ophtha.2007.08.023
Jacobi PC, Miliczek KD, Zrenner E (1993) Experiences with the international standard for clinical electroretinography: normative values for clinical practice, interindividual and intraindividual variations and possible extensions. Doc Ophthalmol 85:95–114
Birch DG, Anderson JL (1992) Standardized full-field electroretinography: normal values and their variation with age. Arch Ophthalmol 110:1571–1576. https://doi.org/10.1001/archopht.1992.01080230071024
Parvaresh MM, Ghiasian L, Ghasemi Falavarjani K et al (2009) Normal values of standard full field electroretinography in an Iranian population. J Ophthalmic Vis Res 4:97–101
Porciatti V, Ventura LM (2004) Normative data for a user-friendly paradigm for pattern electroretinogram recording. Ophthalmology 111:161–168. https://doi.org/10.1016/j.ophtha.2003.04.007
Coupland SG, Wu D (2006) International multicenter normative ERG database using the ISCEV standard. Investig Ophthalmol Vis Sci 47:1669
Trick GL, Nesher R, Cooper DG, Shields SM (1992) The human pattern ERG: alteration of response properties with aging. Optom Vis Sci 69:122–128
Palmowski-Wolfe AM, Woerdehoff U (2005) A comparison of the fast stimulation multifocal-ERG in patients with an IOL and control groups of different age. Doc Ophthalmol 111:87–93. https://doi.org/10.1007/s10633-005-4506-x
Amarasekera DC, Resende AF, Waisbourd M (2018) Steady-state pattern electroretinogram and short-duration transient visual evoked potentials in glaucomatous and healthy eyes. Clin Exp Opthalmol 46:54–61. https://doi.org/10.1111/ceo.13006
Ventura LM, Golubev I, Feuer WJ, Porciatti V (2010) The PERG in diabetic glaucoma suspects with no evidence of retinopathy. J Glaucoma 19:243–247. https://doi.org/10.1097/IJG.0b013e3181a990ea
Pescosolido N, Barbato A (2015) Role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy. J Diabetes Res 2015:319692. https://doi.org/10.1155/2015/319692
Tzekov R, Arden GB (1999) The electroretinogram in diabetic retinopathy. Surv Ophthalmol 44:53–60
Parisi V, Uccioli L (2001) Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab Res Rev 17:12–18
Parisi V, Uccioli L, Parisi L et al (1998) Neural conduction in visual pathways in newly-diagnosed IDDM patients. Electroencephalogr Clin Neurophysiol Potentials Sect 108:490–496. https://doi.org/10.1016/S0168-5597(98)00026-4
Riva CE, Logean E, Falsini B (2005) Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog Retin Eye Res 24:183–215. https://doi.org/10.1016/j.preteyeres.2004.07.002
Nguyen TT, Kawasaki R, Kreis AJ et al (2009) Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Investig Ophthalmol Vis Sci 50:5609–5613. https://doi.org/10.1167/iovs.09-3442
Garhofer G, Zawinka C, Resch H et al (2004) Reduced response of retinal vessel diameters to flicker stimulation in patients with diabetes. Br J Ophthalmol 88:887–891. https://doi.org/10.1136/bjo.2003.033548
Mandecka A, Dawczynski J, Blum M et al (2007) Influence of flickering light on the retinal vessels in diabetic patients. Diabetes Care 30:3048–3052. https://doi.org/10.2337/dc07-0927
Bresnick GH, Korth K, Groo A, Palta M (1984) Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 102:1307–1311
Kim SH, Lee SH, Bae JY et al (1997) Electroretinographic evaluation in adult diabetics. Doc Ophthalmol 94:201–213
Nagy BV, Barboni MT, Martins CM et al (2014) Human flicker electroretinography using different temporal modulations at mesopic and photopic luminance levels. Doc Ophthalmol 129:129–138. https://doi.org/10.1007/s10633-014-9452-z
Domalpally A, Ip MS, Ehrlich JS (2015) Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials. Ophthalmology 122:779–786. https://doi.org/10.1016/j.ophtha.2014.10.028
Writing Committee for the Diabetic Retinopathy Clinical Research N (2015) Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA 314:2137–2146. https://doi.org/10.1001/jama.2015.15217
Pedersen KB, Møller F, Sjølie AK, Andréasson S (2010) Electrophysiological assessment of retinal function during 6 months of bevacizumab treatment in neovascular age-related macular degeneration. Retina 30:1025–1033. https://doi.org/10.1097/IAE.0b013e3181cafc8f
Holm K, Schroeder M, Lovestam Adrian M (2015) Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema. Doc Ophthalmol 131:43–51. https://doi.org/10.1007/s10633-015-9495-9
Yasuda S, Kachi S, Ueno S et al (2015) Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion. Acta Ophthalmol 93:e465–e468. https://doi.org/10.1111/aos.12674
Funding
This study was funded by Dyopsis Inc. Dr. Alberto Garcia, MD works as Chief Medical Officer at Diopsys Inc. Ms. Kassandra Pickel, MPH worked as a Research Associate at Diopsys Inc. during this manuscript’s preparation. The Wills Eye Hospital Glaucoma Research Center has received funding from Diopsys Inc. to conduct this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Statement on the welfare of animals
This manuscript does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Resende, A.F., Sanvicente, C.T., Eshraghi, H. et al. Test–retest repeatability of the pattern electroretinogram and flicker electroretinogram. Doc Ophthalmol 139, 185–195 (2019). https://doi.org/10.1007/s10633-019-09707-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10633-019-09707-5